News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
TDxd for treating HER2-positive breast cancer with brain and/or leptomeningeal metastases
Aug 17, 2024, 14:04

TDxd for treating HER2-positive breast cancer with brain and/or leptomeningeal metastases

Elisabetta Bonzano, Radiation Oncologist at IRCCS San Matteo Polyclinic Foundation, shared on X about recent paper by Takahiro Nakayama et al., titled “Trastuzumab deruxtecan for the treatment of patients with HER2-positive breast cancer with brain and/or leptomeningeal metastases: an updated overall survival analysis using data from a multicenter retrospective study (ROSET-BM)” published on Breast Cancer.

Authors: Takahiro Nakayama, Naoki Niikura, Takashi Yamanaka, Mitsugu Yamamoto, Kazuo Matsuura, Kenichi Inoue, Sachiko Takahara, Hironori Nomura, Shosuke Kita, Miki Yamaguchi, Tomoyuki Aruga, Nobuhiro Shibata, Akihiko Shimomura, Yuri Ozaki, Shuji Sakai, Daisuke Takiguchi, Takehiko Takata, Armin Bastanfard, Kazuhito Shiosakai, Junji Tsurutani

Image

“ Trastuzumab deruxtecan for the treatment of patients with HER2-positive breast cancer with brain and/or leptomeningeal metastases: an updated overall survival analysis using data from a multicenter retrospective study (ROSET-BM) | Breast Cancer.”

Source: Elisabetta Bonzano/X

Akihiko Shimomura Armin Bastanfard Breast Cancer cancer Daisuke Takiguchi Elisabetta Bonzano HER2 positive breast cancer Hironori Nomura IRCCS San Matteo Polyclinic Foundation Junji Tsurutani Kazuhito Shiosakai Kazuo Matsuura Kenichi Inoue leptomeningeal metastases Miki Yamaguchi Mitsugu Yamamoto Naoki Niikura Nobuhiro Shibata OncoDaily Oncology Sachiko Takahara Shosuke Kita Shuji Sakai Takahiro Nakayama Takashi Yamanaka Takehiko Takata Tomoyuki Aruga Trastuzumab deruxtecan Yuri Ozaki
Special Coverage
Career
Apr 15, 2025, 11:46
Merel Hennink has been appointed to the Board of Lung Cancer Europe
Oncolibrary
Apr 15, 2025, 11:34
New Paper Alert: Insights from the PALMARES-2 Study: Improved Outcomes with Abemaciclib and Ribociclib in HR+/HER2- ABC
Blog
Apr 15, 2025, 11:34
Insightful updates and lively discussions at the EUonQoL General Assembly - European Cancer Organisation
Blog
Apr 15, 2025, 11:30
Moshe Ornstein as the moderator for KidneyCAN's upcoming Town Hall
Blog
Apr 15, 2025, 11:20
Support cancer research that creates better treatments for pediatric cancer patients - NFCR
Insight
Apr 15, 2025, 11:00
Roberto Vasquez Sheds Light on LMICs' Struggles with Cancer Drug Access
Blog
Apr 15, 2025, 10:52
The first lectures of the Masterclass on Gynecopathology by Matias-Guiu - European Society of Pathology
Insight
Apr 15, 2025, 10:23
Anna Avagyan on Armenia's ACT4Children Program and Genetic Risk Clinics
Blog
Apr 15, 2025, 10:22
Yizhou Zhang Discusses Innovation in Pediatric Cancer Drug Access in China
Opinion
Apr 15, 2025, 10:17
Scott Howard Advocates for Blinatumomab in WHO’s Essential Medicines List
Science
Apr 15, 2025, 10:09
Myeloma Paper of the Day, April 15th, suggested by Robert Orlowski
Dialogues
Apr 15, 2025, 10:04
Youth Against Tobacco: Dr. Ravi Mehrotra’s Call to Action